BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND KDM5C, XE169, SMCX, JARID1C, 8242, ENSG00000126012, DXS1272E, MRXSJ, MRXJ, RP11-258C19_2
25812 results:

  • 1. Deciphering the progression of fine-needle aspiration: A bibliometric analysis of thyroid nodule research.
    Liu T; Yang F; Qiao J; Mao M
    Medicine (Baltimore); 2024 May; 103(20):e38059. PubMed ID: 38758913
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of thyroid cancer.
    Fu G; Chazen RS; MacMillan C; Witterick IJ
    JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rare Columnar Cell Variant of Papillary thyroid Carcinoma with Cervical Spine Metastasis: A Case Report.
    Yu J; Yang G; Oh HY; Ryu YJ
    Curr Med Imaging; 2024; 20(1):e15734056300884. PubMed ID: 38752631
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Trends and projections of the global burden of thyroid cancer from 1990 to 2030.
    Hu S; Wu X; Jiang H
    J Glob Health; 2024 May; 14():04084. PubMed ID: 38751316
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Feasibility and complications after transoral endoscopic thyroidectomy via vestibular approach (TOETVA) - a single-center first experience case series.
    Kinet S; van Weezelenburg MAS; Pijnenburg A; Stoot JHMB; van Bastelaar J
    Langenbecks Arch Surg; 2024 May; 409(1):158. PubMed ID: 38748236
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RPGRIP1L as a new biomarker for prognosis and tumor immune of breast cancer.
    Yi J; Liu L; Chen Y; Ding T; Fan P; Yu J; Zeng J
    FASEB J; 2024 May; 38(9):e23624. PubMed ID: 38747001
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Imaging characteristics and diagnosis of primary middle mediastinal tumors].
    Chen JQ; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):449-456. PubMed ID: 38742358
    [No Abstract]    [Full Text] [Related]  

  • 8. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
    Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cyclometalated and NNN Terpyridine Ruthenium Photocatalysts and Their Cytotoxic Activity.
    Ballico M; Alessi D; Aneggi E; Busato M; Zuccaccia D; Allegri L; Damante G; Jandl C; Baratta W
    Molecules; 2024 May; 29(9):. PubMed ID: 38731639
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. In situ ascending aortic thrombus in a patient with metastatic lung adenocarcinoma and no aortic atherosclerosis or cisplatin exposure: a case report.
    Mehta C; Raza F
    J Med Case Rep; 2024 May; 18(1):243. PubMed ID: 38730499
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Columnar Cell thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary thyroid Carcinoma and Follicular Neoplasms.
    Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
    Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell thyroid Carcinoma.
    Tian Y; He L; Zhang B; Deng L; Wang J
    Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
    [No Abstract]    [Full Text] [Related]  

  • 13. Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance.
    Zheng W; Tang X; Dong J; Feng J; Chen M; Zhu X
    Sci Rep; 2024 May; 14(1):10546. PubMed ID: 38719979
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
    Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
    World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification and Economic Evaluation of Differentiated thyroid cancer Care Consumption Patterns Using Sequence Analysis.
    Demeulemeester R; Grosclaude P; Grunenwald S; Saint-Pierre P; Savy N; Costa N
    Int J Public Health; 2024; 69():1606664. PubMed ID: 38707870
    [No Abstract]    [Full Text] [Related]  

  • 18. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
    Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
    Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
    Zhang Q; Zhong ZZ; Wu T; He YQ
    BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Assessing the relative effectiveness of various ultrasound-guided ablation techniques for treating benign thyroid nodules: A systematic review and network meta-analysis.
    Sun X; Chen J; Zou Y; Lei J; Liu W
    Medicine (Baltimore); 2024 May; 103(18):e38014. PubMed ID: 38701262
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1291.